Currently being studied is the possibility of adding ONC201 to combination chemotherapy regimens, targeting the DNA of the tumor cells along in addition to activating the integrated stress response, thus, inducing higher levels of cleaved PARP, resulting in a synergistic pro-apoptotic effect. This evidence concerns the gene PARP1 and neoplasm.